The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated Signaling

This publication has 56 references indexed in Scilit:

• Differential Modulation of Mitogen-activated Protein (MAP) Kinase/Extracellular Signal-related Kinase Kinase and MAP Kinase Activities by a Mutant Epidermal Growth Factor Receptor
  Journal of Biological Chemistry, 1995
• Amplification of the epidermal‐growth‐factor‐receptor gene correlates with different growth behaviour in human glioblastoma
  International Journal of Cancer, 1994
• Tissue-Specific Transformation by Oncogenic Mutants of Epidermal Growth Factor Receptor
  Critical Reviews™ in Oncogenesis, 1994
• Immunodetection of the Ligand-Activated Receptor for Epidermal Growth Factor
  Growth Factors, 1991
• Intermolecular association of the p185 protein and EGF receptor modulates EGF receptor function
  Cell, 1990
• c-erbB activation in ALV-induced erythroblastosis: novel RNA processing and promoter insertion result in expression of an amino-truncated EGF receptor
  Cell, 1985
• Protein phosphorylation at tyrosine is induced by the v-erbB gene product in vivo and in vitro
  Cell, 1985
• Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin
  Nature, 1985
• Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells
  Nature, 1984
• Transforming capacities of avian erythroblastosis virus mutants deleted in the erbA or erbB oncogenes
  Cell, 1983